CME.NASDAQCme Group INC

Form 4: CME Exec Sammann Reports Stock Acquisitions, Tax Sales

Sentiment:

Insider Trading Report


CME Group Senior Managing Director Derek Sammann reported recent acquisitions and tax-related dispositions of company stock.

Summary

  • Derek Sammann, Senior Managing Director and Global Head of Commodities Markets at CME Group Inc., reported transactions involving the company's Class A Common Stock.
  • On September 15, 2025, Sammann acquired 3,044 shares of Class A Common Stock at a price of $258.83 per share.
  • On the same date, September 15, 2025, he disposed of 1,099 shares of Class A Common Stock at $258.83 to fulfill tax withholding obligations upon the vesting of restricted stock.
  • An additional 379 shares of Class A Common Stock were disposed of on September 16, 2025, at $259.83, also for tax withholding related to restricted stock vesting.
  • Following these transactions, Sammann directly holds 10,983 shares of Class A Common Stock.
  • He also indirectly holds 14,614 shares through a trust and 8,336 shares through his spouse.

Sentiment

Score: 7

Explanation: The filing details routine executive stock transactions, including an acquisition of shares and dispositions for tax purposes, which is generally neutral to slightly positive as it reflects ongoing executive compensation and a net increase in direct holdings.

Positives

  • Acquisition of 3,044 shares of Class A Common Stock by a senior executive, indicating continued confidence in the company's future.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Industry Context

This Form 4 filing details routine insider transactions, which are common for executives receiving equity compensation. It does not provide broader industry context or trends.

Related Party Transactions

  • Transactions between Derek Sammann, a senior executive, and CME Group Inc. related to the vesting of restricted stock and subsequent tax withholding obligations.

Stakeholder Impact

  • Shareholders: The acquisition of 3,044 shares by a senior executive could be viewed as a minor positive signal of management's confidence in the company's future.
  • Employees: No direct impact on the broader employee base.
  • Customers/Suppliers/Creditors: No direct impact.

Key Dates

DateDescription
09/15/2025Acquisition of 3,044 shares and disposition of 1,099 shares for tax withholding upon restricted stock vesting.
09/16/2025Disposition of 379 shares for tax withholding upon restricted stock vesting.
09/17/2025Date of filing signature.

Recommendation

hold

This Form 4 filing details routine executive stock transactions, including the vesting of restricted stock, an acquisition of shares, and subsequent dispositions for tax withholding. While the executive acquired a notable number of shares, indicating continued confidence, the overall activity is part of a standard compensation package and does not present new information that would significantly alter the investment thesis for CME Group. Therefore, a 'hold' recommendation is appropriate as the filing does not provide a strong catalyst for either buying or selling.

Keywords

CME Group, CME, Derek Sammann, Form 4, Insider Trading, Stock Transactions, Executive Compensation, Restricted Stock, Commodities Markets

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.